• 1

    Noma M, Nwoke BE, Nutall I, Tambala PA, Enyong P, Namsenmo A, Remme J, Amazigo UV, Kale OO, Seketeli A, 2002. Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol 96 (Suppl 1):S29–S39.

    • Search Google Scholar
    • Export Citation
  • 2

    Kaiser C, Kipp W, Asaba G, Mugisa C, Kabagambe G, Rating D, Leichsenring M, 1996. The prevalence of epilepsy follows the distribution of onchocerciasis in a west Uganda focus. Bull World Health Organ 74 :361–367.

    • Search Google Scholar
    • Export Citation
  • 3

    Benoit M, Boussinesq M, Druet-Cabanac MI, Kamgno J, Bouteille B, Preux P, 2006. Onchocercerciasis-related epilepsy? Prospects at a time of uncertainty. Trends Parasitol 22 :17–20.

    • Search Google Scholar
    • Export Citation
  • 4

    Phiri IK, Ngowi H, Afonso S, Matenga E, Boa M, Mukaratirwa S, Githigia S, Saimo M, Sikasunge C, Maingi N, Lubega GW, Kassuku A, Michael L, Siziya S, Krecek RCK, Noormahomed E, Vilhena M, Dorny PA, Willingham L III, 2003. The emergence of Taenia solium cysticercosis in Eastern and Southern Africa as a serious agricultural problem and public health risk. Acta Trop 87 :13–23.

    • Search Google Scholar
    • Export Citation
  • 5

    Garcia HG, Gonzalez I, Mija L, 2007. Neurocysticercosis uncovered by single-dose albendazole. New Engl J Med 356 :1277–1278.

Past two years Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 216 103 1
PDF Downloads 51 30 1
 
 
 
 
 
 
 
 
 
 
 

Could Neurocysticercosis Be the Cause of “Onchocerciasis-Associated” Epileptic Seizures?

Moses KatabarwaThe Carter Center, Atlanta, Georgia (USA and Uganda); Ministry of Health (Uganda); Centers for Disease Control and Prevention, Atlanta, Georgia

Search for other papers by Moses Katabarwa in
Current site
Google Scholar
PubMed
Close
,
Tom LakwoThe Carter Center, Atlanta, Georgia (USA and Uganda); Ministry of Health (Uganda); Centers for Disease Control and Prevention, Atlanta, Georgia

Search for other papers by Tom Lakwo in
Current site
Google Scholar
PubMed
Close
,
Peace HabumogishaThe Carter Center, Atlanta, Georgia (USA and Uganda); Ministry of Health (Uganda); Centers for Disease Control and Prevention, Atlanta, Georgia

Search for other papers by Peace Habumogisha in
Current site
Google Scholar
PubMed
Close
,
Frank RichardsThe Carter Center, Atlanta, Georgia (USA and Uganda); Ministry of Health (Uganda); Centers for Disease Control and Prevention, Atlanta, Georgia

Search for other papers by Frank Richards in
Current site
Google Scholar
PubMed
Close
, and
Mark EberhardThe Carter Center, Atlanta, Georgia (USA and Uganda); Ministry of Health (Uganda); Centers for Disease Control and Prevention, Atlanta, Georgia

Search for other papers by Mark Eberhard in
Current site
Google Scholar
PubMed
Close
View More View Less
Restricted access

We conducted a nodule prevalence survey in four onchocerciasis sentinel communities in Moyo and two in Kanungu districts of Uganda. Seven (33.3%) out of 21 excised “onchocercomas” (nodules) in Moyo District and excised onchocercomas from four of six persons in Kanungu District turned out to be cysts of Taenia solium. We concluded that the prediction of nodule prevalence for noninvasive rapid epidemiologic assessment (REA) to target areas for mass chemotherapy with ivermectin in the African Program for Onchocerciasis Control (APOC) supported areas may have been influenced by other pathologies. T. solium infection may be the main cause of “onchocerciasis-associated epileptic seizures” in many onchocerciasis endemic communities that have been causally linked to onchocerciasis. Lastly, widespread neurocysticercosis may be a concern in mass treatment programs that provide praziquantel (for managing schistosomiasis) or albendazole (for managing intestinal worms or lymphatic filariasis) because these drugs may kill cerebral cysticerci, resulting in severe adverse events.

Save